Rite Aid Corporation (NYSE:RAD) Files An 8-K Shareholder Director Nominations
Item 5.08. Shareholder Director Nominations.
To the extent applicable, the information in Item 8.01 of this report is incorporated by reference into this Item 5.08.
Item 8.01. Other Events.
The board of directors (the “Board”) of Rite Aid Corporation (the “Company”) has established July 17, 2019 as the date of the Company’s 2019 annual meeting of stockholders (the “2019 Annual Meeting”). This date represents a change of more than 25 days from the anniversary date of the Company’s 2018 annual meeting of stockholders held on October 30, 2018. As a result, the deadlines for stockholders to submit proposals and nominations of directors as set forth in Rite Aid’s definitive proxy statement for the Company’s 2018 annual meeting of stockholders are no longer effective.
Under the Company’s amended and restated By-Laws (as so amended and restated, the “By-Laws”), in order for stockholder proposals and director nominations to be presented at the 2019 Annual Meeting (other than by means of inclusion of a stockholder proposal in the proxy materials under Rule14a-8 and proxy access nominations, which are each described below), the Company must have received proper notice at the Company’s principal executive offices not later than the close of business on January 18, 2019. The notice must include all of the information required by the Company’s By-Laws.
Under the Company’s By-Laws, in order for proxy access nominations to be included in the Company’s proxy materials and presented at the 2019 Annual Meeting, the Company must have received proper notice at the Company’s principal executive offices not before February 2, 2019 and not later than the close of business on March 4, 2019. The notice must include all of the information required by the Company’s By-Laws.
Stockholder proposals intended for inclusion in the Company’s definitive proxy statement for the 2019 Annual Meeting to Rule14a-8 under the Securities Exchange Act of 1934, as amended, must be received at Rite Aid’s principal executive offices no later than February 8, 2019 (which the Company believes is a reasonable time before it begins to print and send its proxy materials).
All proposals and nominations must be addressed to the Secretary of the Company at “Rite Aid Corporation, 30 Hunter Lane, Camp Hill, Pennsylvania 17011, Attention: James J. Comitale, Secretary.”
About Rite Aid Corporation (NYSE:RAD)
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company’s Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.
